Please wait while the formulary information is being retrieved.
INDAPAMIDE (INDAPAMIDE)
- Edema
- Hypertension
1.25 mg tablet
- 1 tablet (1.25 mg) by oral route once daily in the morning
2.5 mg tablet
- 1 tablet (2.5 mg) by oral route once daily in the morning
1.25 mg tablet
- 1 tablet (1.25 mg) by oral route once daily in the morning
2.5 mg tablet
- 1 tablet (2.5 mg) by oral route once daily in the morning
Edema
- 2 tablets (5 mg) by oral route once daily in the morning
- 2 tablets (2.5 mg) by oral route once daily in the morning
- 1 tablet (2.5 mg) by oral route once daily in the morning
Hypertension
- 2 tablets (5 mg) by oral route once daily in the morning
- 1 tablet (1.25 mg) by oral route once daily in the morning
- 2 tablets (2.5 mg) by oral route once daily in the morning
- 1 tablet (2.5 mg) by oral route once daily in the morning
- dofetilide
- Tikosyn
Contraindicated
- Curad Enema
- Disposable Enema
- Enema
- Enema Disposable
- Fleet Enema
- Fleet Enema Extra
- Fleet Pediatric
- lithium carbonate
- lithium citrate
- Lithobid
- Oral Saline Laxative
- Osmoprep
- Phosphate Laxative
- Preparation Cleansing
- Ready-to-use Enema
- Reclast
- sod phos mono-sod phos dibasic
- sodium phosphates
- zoledronic acid
- zoledronic acid-mannitol-water
- Zometa
Severe
Moderate
- acarbose
- Amaryl
- Apidra
- Apidra Solostar
- cholestyramine (with sugar)
- Cholestyramine Light
- cholestyramine-aspartame
- Colestid
- Colestid Flavored
- colestipol
- Diabeta
- diazoxide
- Digox
- digoxin
- Duetact
- glimepiride
- glipizide
- glipizide-metformin
- Glucotrol
- Glucotrol Xl
- Glucovance
- glyburide
- glyburide micronized
- glyburide-metformin
- Glynase
- Glyset
- Humalog
- Humalog Kwikpen
- Humalog Mix 50-50
- Humalog Mix 50-50 Kwikpen
- Humalog Mix 75-25
- Humalog Mix 75-25 Kwikpen
- Humulin 70/30
- Humulin N
- Humulin N Kwikpen
- Humulin R
- Humulin R U-500 "Concentrated"
- insulin asp prt-insulin aspart
- insulin aspart
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin lispro
- insulin lispro protam-lispro
- insulin NPH and regular human
- insulin regular hum U-500 conc
- insulin regular human
- Lanoxin
- Lanoxin Pediatric
- Lantus
- Lantus Solostar
- Levemir
- Levemir Flexpen
- miglitol
- nateglinide
- Novolin 70/30
- Novolin N
- Novolin R
- Novolog
- Novolog Flexpen
- Novolog Mix 70-30
- Novolog Mix 70-30 Flexpen
- Novolog Penfill
- NPH insulin human recomb
- pioglitazone-glimepiride
- Precose
- Prevalite
- Proglycem
- Questran
- Questran Light
- Starlix
- tolazamide
- tolbutamide
- Anuria
Contraindicated
- Dehydration
- Hypokalemia
- Hyponatremia
- Oliguria
- Severe renal impairment
Severe
Moderate
- Diabetes mellitus
- Disease of liver
- Gout
- Hyperparathyroidism
- Hyperuricemia
- Sympathectomy
INDAPAMIDE (INDAPAMIDE)
- Edema
- Hypertension
- Hypokalemia
- Infection
- Back pain
- Dizziness
- Headache disorder
- Pain
- Rhinitis
More Frequent
Severe
Less Severe
- Vasculitis
- Ventricular premature beats
- Acute abdominal pain
- Agitation
- Anorexia
- Blurred vision
- Chest pain
- Conjunctivitis
- Constipation
- Cough
- Depression
- Diarrhea
- Drowsy
- Dyspepsia
- Fatigue
- Flu-like symptoms
- Flushing
- General weakness
- Hypertonia
- Increased urinary frequency
- Libido changes
- Nausea
- Nervousness
- Nocturia
- Palpitations
- Paresthesia
- Peripheral edema
- Pharyngitis
- Sinusitis
- Vertigo
- Weight loss
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute gouty arthritis
- Allergic dermatitis
- Hypercalcemia
- Hyperglycemia
- Hyperuricemia
- Hypochloremic alkalosis
- Hyponatremia
- Hypophosphatemia
- Pruritus of skin
- Skin rash
- Systemic lupus erythematosus
- Urticaria
Less Severe
- Insomnia
- Orthostatic hypotension
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Indapamide
No safety and efficacy established.
- 1 Day – 18 Years
- No safety and efficacy established.
Indapamide
- Severity Level:
B
- Additional Notes: Not recommended in pre-eclampsia and other pregnancy-induced hypertension
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Indapamide
Insufficient data available.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Indapamide
Cardiovascular-Elderly are more sensitive to hypotensive effects. Metabolic-Elderly are more sensitive to drug induced electrolyte loss. Monitor serum potassium, magnesium, and sodium.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | Y | Y | N | N | Y |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- None
Edema | |
R60 | Edema, not elsewhere classified |
R60.0 | Localized edema |
R60.1 | Generalized edema |
R60.9 | Edema, unspecified |
Hypertension | |
I10 | Essential (primary) hypertension |
I11 | Hypertensive heart disease |
I11.0 | Hypertensive heart disease with heart failure |
I11.9 | Hypertensive heart disease without heart failure |
I12 | Hypertensive chronic kidney disease |
I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13 | Hypertensive heart and chronic kidney disease |
I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
I15.1 | Hypertension secondary to other renal disorders |
0-9 | A-Z |
---|---|
I10 | Essential (primary) hypertension |
I11 | Hypertensive heart disease |
I11.0 | Hypertensive heart disease with heart failure |
I11.9 | Hypertensive heart disease without heart failure |
I12 | Hypertensive chronic kidney disease |
I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13 | Hypertensive heart and chronic kidney disease |
I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
I15.1 | Hypertension secondary to other renal disorders |
R60 | Edema, not elsewhere classified |
R60.0 | Localized edema |
R60.1 | Generalized edema |
R60.9 | Edema, unspecified |
Formulary Reference Tool